FDA Calling For Further Research On Earlier Stages Of Alzheimer’s.

Healio (11/29) reports the Food and Drug Administration “is calling for further research on earlier stages of Alzheimer’s disease to attack the disorder head on.” In a press release, Eric Bastings, MD, deputy director of FDA’s Division of Neurology Products, said, “There may be a window of opportunity to affect the disease before people experience symptoms.”

Related Links:

— “FDA calls for more research in early Alzheimer’s disease, Healio, November 29, 2016.

Posted in In The News.